Aquestive Therapeutics, Inc. (AQST)
4.07
+0.10
(+2.52%)
USD |
NASDAQ |
Oct 27, 16:00
4.055
-0.02
(-0.37%)
After-Hours: 20:00
Aquestive Therapeutics Price : 4.07 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 4.00 | 4.075 | 3.92 | 4.07 | 1.325M |
| Oct 26, 2026 | 4.00 | 4.04 | 3.935 | 3.97 | 1.273M |
| Oct 23, 2026 | 4.08 | 4.135 | 3.97 | 4.00 | 1.747M |
| Oct 22, 2026 | 4.10 | 4.160 | 4.04 | 4.13 | 1.853M |
| Oct 21, 2026 | 4.08 | 4.185 | 4.020 | 4.08 | 1.573M |
| Oct 20, 2026 | 3.83 | 4.13 | 3.79 | 4.05 | 2.260M |
| Oct 19, 2026 | 3.80 | 3.85 | 3.65 | 3.83 | 3.335M |
| Oct 16, 2026 | 4.09 | 4.10 | 3.75 | 3.78 | 5.253M |
| Oct 15, 2026 | 4.67 | 4.715 | 3.99 | 4.06 | 5.470M |
| Oct 14, 2026 | 4.73 | 4.73 | 4.57 | 4.61 | 1.602M |
| Oct 13, 2026 | 4.80 | 4.81 | 4.67 | 4.67 | 1.400M |
| Oct 12, 2026 | 4.77 | 4.89 | 4.734 | 4.81 | 957525.0 |
| Oct 09, 2026 | 4.78 | 4.975 | 4.74 | 4.78 | 1.692M |
| Oct 08, 2026 | 4.62 | 4.85 | 4.55 | 4.76 | 2.320M |
| Oct 07, 2026 | 4.58 | 4.665 | 4.530 | 4.62 | 1.357M |
| Oct 06, 2026 | 4.62 | 4.645 | 4.46 | 4.61 | 1.209M |
| Oct 05, 2026 | 4.57 | 4.61 | 4.455 | 4.57 | 1.093M |
| Oct 02, 2026 | 4.53 | 4.595 | 4.425 | 4.55 | 2.273M |
| Oct 01, 2026 | 4.60 | 4.61 | 4.435 | 4.44 | 2.687M |
| Sep 30, 2026 | 4.73 | 4.74 | 4.615 | 4.63 | 2.413M |
| Sep 29, 2026 | 4.70 | 4.75 | 4.55 | 4.67 | 1.708M |
| Sep 28, 2026 | 4.64 | 4.775 | 4.57 | 4.75 | 1.277M |
| Sep 25, 2026 | 4.82 | 4.86 | 4.66 | 4.68 | 1.910M |
| Sep 24, 2026 | 4.69 | 4.85 | 4.625 | 4.82 | 3.007M |
| Sep 23, 2026 | 4.92 | 5.005 | 4.70 | 4.70 | 1.952M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eton Pharmaceuticals, Inc. | 51.16 |
| LENZ Therapeutics, Inc. | 3.15 |
| ANI Pharmaceuticals, Inc. | 71.17 |
| Corcept Therapeutics, Inc. | 87.59 |
| Veru, Inc. | 2.28 |
Price Related Metrics
| PS Ratio | 9.033 |
| Earnings Yield | -15.96% |
| Market Cap | 510.83M |